APA (7th ed.) Citation

Anthony M. Marchese, Raj Kalkeri, Muruga Vadivale, Nungruthai Suntronwong, Seth Toback, & Yong Poovorawan. (2023). Pivoting to protein: The immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Anthony M. Marchese, Raj Kalkeri, Muruga Vadivale, Nungruthai Suntronwong, Seth Toback, and Yong Poovorawan. Pivoting to Protein: The Immunogenicity and Safety of Protein-based NVX-CoV2373 as a Heterologous Booster for Inactivated and Viral Vector COVID-19 Vaccines. Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

Anthony M. Marchese, et al. Pivoting to Protein: The Immunogenicity and Safety of Protein-based NVX-CoV2373 as a Heterologous Booster for Inactivated and Viral Vector COVID-19 Vaccines. Taylor & Francis Group, 2023.